Revance Therapeutics Inc (NASDAQ:RVNC)

27.02
Delayed Data
As of Sep 30
 +1.35 / +5.26%
Today’s Change
11.27
Today|||52-Week Range
29.51
+65.56%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close25.67
Today’s open25.68
Day’s range25.68 - 27.31
Volume105,089
Average volume (3 months)1,136,868
Market cap$2.0B
Data as of 4:01pm ET, 09/30/2022

Growth & Valuation

Earnings growth (last year)+14.31%
Earnings growth (this year)+16.44%
Earnings growth (next 5 years)+192.00%
Revenue growth (last year)+407.65%
P/E ratioNM
Price/Sales14.16
Price/Book26.17

Competitors

 Today’s
change
Today’s
% change
XENEXenon Pharmaceutical...+0.20+0.56%
----
ISEEIVERIC bio Inc+0.62+3.58%
----
Data as of 4:02pm ET, 09/30/2022

Financials

Next reporting dateNovember 3, 2022
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$77.8M
Annual profit (last year)-$281.3M
Net profit margin-361.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Nashville, Tennessee

Forecasts